ZTS
Zoetis Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$75.81
−0.63%Margins
Gross margin
70.9%
EBITDA margin
40.7%
EBIT margin
37.0%
Net margin
27.5%
FCF margin
24.9%
83.1%
Return on equity
17.4%
Return on assets
28.4%
Return on invested capital
0.63x
Asset turnover
$2.9B
Cash from operations
$4.06
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026